Managing Partner Michael Abrams spoke with FierceHealthcare on the Trump Administration requiring drug prices to be in consumer advertisements. He told Fierce that list prices could even deter patients from filling prescriptions entirely.

“People who misunderstand those commercials, who think the list price is what they will pay, may be less inclined to have those scripts filled. True transparency means making that complexity go away.”

Read the full article at FierceHealthcare: Trump administration’s push for prices in drug ads facing a likely legal fight